{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T17:43:18Z","timestamp":1789580598346,"version":"build-2803163510"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2024,3,20]],"date-time":"2024-03-20T00:00:00Z","timestamp":1710892800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,3,20]],"date-time":"2024-03-20T00:00:00Z","timestamp":1710892800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"NIH\/NCI Cancer Center Support","award":["P30 CA008748."],"award-info":[{"award-number":["P30 CA008748."]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur Radiol"],"DOI":"10.1007\/s00330-024-10671-1","type":"journal-article","created":{"date-parts":[[2024,3,20]],"date-time":"2024-03-20T16:02:55Z","timestamp":1710950575000},"page":"6896-6907","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["MRI imaging features for predicting macrotrabecular-massive subtype hepatocellular carcinoma: a systematic review and meta-analysis"],"prefix":"10.1007","volume":"34","author":[{"given":"Tae-Hyung","family":"Kim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sungmin","family":"Woo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong Ho","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard K.","family":"Do","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5715-1403","authenticated-orcid":false,"given":"Victoria","family":"Chernyak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,3,20]]},"reference":[{"key":"10671_CR1","first-page":"e19274","volume":"13","author":"CA Philips","year":"2021","unstructured":"Philips CA, Rajesh S, Nair DC, Ahamed R, Abduljaleel JK, Augustine P (2021) Hepatocellular Carcinoma in 2021: an exhaustive update. Cureus 13:e19274","journal-title":"Cureus"},{"key":"10671_CR2","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1111\/his.13975","volume":"76","author":"ID Nagtegaal","year":"2020","unstructured":"Nagtegaal ID, Odze RD, Klimstra D et al (2020) The 2019 WHO classification of tumours of the digestive system. Histopathology 76:182\u2013188","journal-title":"Histopathology"},{"key":"10671_CR3","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1002\/hep.29762","volume":"68","author":"M Ziol","year":"2018","unstructured":"Ziol M, Pot\u00e9 N, Amaddeo G et al (2018) Macrotrabecular-massive hepatocellular carcinoma: a distinctive histological subtype with clinical relevance. Hepatology 68:103\u2013112","journal-title":"Hepatology"},{"key":"10671_CR4","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.humpath.2021.04.008","volume":"113","author":"D Kumar","year":"2021","unstructured":"Kumar D, Hafez O, Jain D, Zhang X (2021) Can primary hepatocellular carcinoma histomorphology predict extrahepatic metastasis? Hum Pathol 113:39\u201346","journal-title":"Hum Pathol"},{"key":"10671_CR5","doi-asserted-by":"crossref","unstructured":"(2018) EASL Clinical Practice Guidelines: management of hepatocellular carcinoma. J Hepatol 69:182-236","DOI":"10.1016\/j.jhep.2018.03.019"},{"key":"10671_CR6","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1002\/hep.29913","volume":"68","author":"JA Marrero","year":"2018","unstructured":"Marrero JA, Kulik LM, Sirlin CB et al (2018) Diagnosis, staging, and management of hepatocellular carcinoma: 2018 Practice Guidance by the American Association for the Study of Liver Diseases. Hepatology 68:723\u2013750","journal-title":"Hepatology"},{"key":"10671_CR7","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1097\/MEG.0000000000002525","volume":"35","author":"Y Yang","year":"2023","unstructured":"Yang Y, Mao S, Fang J et al (2023) Macrotrabecular-massive subtype-based nomogram to predict early recurrence of hepatocellular carcinoma after surgery. Eur J Gastroenterol Hepatol 35:505\u2013511","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10671_CR8","doi-asserted-by":"publisher","first-page":"2768","DOI":"10.1007\/s10620-023-07857-w","volume":"68","author":"Y Yang","year":"2023","unstructured":"Yang Y, Sun JH, Tan XY et al (2023) MTM-HCC at previous liver resection as a predictor of overall survival in salvage liver transplantation. Dig Dis Sci 68:2768\u20132777","journal-title":"Dig Dis Sci"},{"key":"10671_CR9","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1007\/s00262-020-02691-9","volume":"70","author":"LL Liu","year":"2021","unstructured":"Liu LL, Zhang SW, Chao X et al (2021) Coexpression of CMTM6 and PD-L1 as a predictor of poor prognosis in macrotrabecular-massive hepatocellular carcinoma. Cancer Immunol Immunother 70:417\u2013429","journal-title":"Cancer Immunol Immunother"},{"key":"10671_CR10","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1186\/s13244-022-01333-1","volume":"13","author":"I Bilal Masokano","year":"2022","unstructured":"Bilal Masokano I, Pei Y, Chen J et al (2022) Development and validation of MRI-based model for the preoperative prediction of macrotrabecular hepatocellular carcinoma subtype. Insights Imaging 13:201","journal-title":"Insights Imaging"},{"key":"10671_CR11","doi-asserted-by":"publisher","first-page":"100380","DOI":"10.1016\/j.jhepr.2021.100380","volume":"3","author":"R Cannella","year":"2021","unstructured":"Cannella R, DioguardiBurgio M, Beaufr\u00e8re A et al (2021) Imaging features of histological subtypes of hepatocellular carcinoma: implication for LI-RADS. JHEP Rep 3:100380","journal-title":"JHEP Rep"},{"key":"10671_CR12","doi-asserted-by":"publisher","first-page":"7696","DOI":"10.1007\/s00330-021-07898-7","volume":"31","author":"J Chen","year":"2021","unstructured":"Chen J, Xia C, Duan T et al (2021) Macrotrabecular-massive hepatocellular carcinoma: imaging identification and prediction based on gadoxetic acid-enhanced magnetic resonance imaging. Eur Radiol 31:7696\u20137704","journal-title":"Eur Radiol"},{"key":"10671_CR13","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1148\/radiol.2021204352","volume":"300","author":"HJ Kang","year":"2021","unstructured":"Kang HJ, Kim H, Lee DH et al (2021) Gadoxetate-enhanced MRI features of proliferative hepatocellular carcinoma are prognostic after surgery. Radiology 300:572\u2013582","journal-title":"Radiology"},{"key":"10671_CR14","doi-asserted-by":"publisher","first-page":"110356","DOI":"10.1016\/j.ejrad.2022.110356","volume":"153","author":"Y Liang","year":"2022","unstructured":"Liang Y, Xu F, Wang Z et al (2022) A gadoxetic acid-enhanced MRI-based multivariable model using LI-RADS v2018 and other imaging features for preoperative prediction of macrotrabecular-massive hepatocellular carcinoma. Eur J Radiol 153:110356","journal-title":"Eur J Radiol"},{"key":"10671_CR15","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1148\/radiol.2020192230","volume":"295","author":"S Mul\u00e9","year":"2020","unstructured":"Mul\u00e9 S, GallettoPregliasco A, Tenenhaus A et al (2020) Multiphase liver MRI for identifying the macrotrabecular-massive subtype of hepatocellular carcinoma. Radiology 295:562\u2013571","journal-title":"Radiology"},{"key":"10671_CR16","doi-asserted-by":"publisher","first-page":"1342","DOI":"10.1007\/s00330-022-09085-8","volume":"33","author":"S Mul\u00e9","year":"2023","unstructured":"Mul\u00e9 S, Serhal A, Pregliasco AG et al (2023) MRI features associated with HCC histologic subtypes: a western American and European bicenter study. Eur Radiol 33:1342\u20131352","journal-title":"Eur Radiol"},{"key":"10671_CR17","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/j.jhep.2020.08.013","volume":"74","author":"H Rhee","year":"2021","unstructured":"Rhee H, Cho ES, Nahm JH et al (2021) Gadoxetic acid-enhanced MRI of macrotrabecular-massive hepatocellular carcinoma and its prognostic implications. J Hepatol 74:109\u2013121","journal-title":"J Hepatol"},{"key":"10671_CR18","doi-asserted-by":"publisher","first-page":"1138848","DOI":"10.3389\/fonc.2023.1138848","volume":"13","author":"L Yang","year":"2023","unstructured":"Yang L, Wang M, Zhu Y et al (2023) Corona enhancement combined with microvascular invasion for prognosis prediction of macrotrabecular-massive hepatocellular carcinoma subtype. Front Oncol 13:1138848","journal-title":"Front Oncol"},{"key":"10671_CR19","doi-asserted-by":"publisher","first-page":"3139","DOI":"10.1007\/s00261-021-02989-x","volume":"46","author":"Y Zhu","year":"2021","unstructured":"Zhu Y, Weng S, Li Y et al (2021) A radiomics nomogram based on contrast-enhanced MRI for preoperative prediction of macrotrabecular-massive hepatocellular carcinoma. Abdom Radiol (NY) 46:3139\u20133148","journal-title":"Abdom Radiol (NY)"},{"key":"10671_CR20","unstructured":"American College of Radiology (ACR). Liver Imaging Reporting and Data System version 2018. ACR web site. Available via https:\/\/www.acr.org\/Clinical-Resources\/Reporting-and-Data-Systems\/LI-RADS. Accessed April 28 2023"},{"key":"10671_CR21","doi-asserted-by":"publisher","first-page":"m2632","DOI":"10.1136\/bmj.m2632","volume":"370","author":"JP Salameh","year":"2020","unstructured":"Salameh JP, Bossuyt PM, McGrath TA et al (2020) Preferred reporting items for systematic review and meta-analysis of diagnostic test accuracy studies (PRISMA-DTA): explanation, elaboration, and checklist. BMJ 370:m2632","journal-title":"BMJ"},{"key":"10671_CR22","doi-asserted-by":"publisher","first-page":"529","DOI":"10.7326\/0003-4819-155-8-201110180-00009","volume":"155","author":"PF Whiting","year":"2011","unstructured":"Whiting PF, Rutjes AW, Westwood ME et al (2011) QUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studies. Ann Intern Med 155:529\u2013536","journal-title":"Ann Intern Med"},{"key":"10671_CR23","doi-asserted-by":"publisher","first-page":"982","DOI":"10.1016\/j.jclinepi.2005.02.022","volume":"58","author":"JB Reitsma","year":"2005","unstructured":"Reitsma JB, Glas AS, Rutjes AW, Scholten RJ, Bossuyt PM, Zwinderman AH (2005) Bivariate analysis of sensitivity and specificity produces informative summary measures in diagnostic reviews. J Clin Epidemiol 58:982\u2013990","journal-title":"J Clin Epidemiol"},{"key":"10671_CR24","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","volume":"327","author":"JP Higgins","year":"2003","unstructured":"Higgins JP, Thompson SG, Deeks JJ, Altman DG (2003) Measuring inconsistency in meta-analyses. BMJ 327:557\u2013560","journal-title":"BMJ"},{"key":"10671_CR25","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1001\/jama.2017.19163","volume":"319","author":"MDF McInnes","year":"2018","unstructured":"McInnes MDF, Moher D, Thombs BD et al (2018) Preferred Reporting Items for a Systematic Review and Meta-analysis of Diagnostic Test Accuracy Studies: the PRISMA-DTA statement. JAMA 319:388\u2013396","journal-title":"JAMA"},{"key":"10671_CR26","doi-asserted-by":"publisher","first-page":"1364","DOI":"10.1007\/s00330-022-09105-7","volume":"33","author":"H Cha","year":"2023","unstructured":"Cha H, Choi JY, Park YN et al (2023) Comparison of imaging findings of macrotrabecular-massive hepatocellular carcinoma using CT and gadoxetic acid-enhanced MRI. Eur Radiol 33:1364\u20131377","journal-title":"Eur Radiol"},{"key":"10671_CR27","doi-asserted-by":"publisher","first-page":"e239001","DOI":"10.1148\/rg.239001","volume":"43","author":"KJ Fowler","year":"2023","unstructured":"Fowler KJ, Bashir MR, Fetzer DT et al (2023) Universal liver imaging Lexicon: imaging atlas for research and clinical practice. Radiographics 43:e239001","journal-title":"Radiographics"},{"key":"10671_CR28","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1007\/s00109-002-0380-0","volume":"80","author":"KR Kim","year":"2002","unstructured":"Kim KR, Moon HE, Kim KW (2002) Hypoxia-induced angiogenesis in human hepatocellular carcinoma. J Mol Med (Berl) 80:703\u2013714","journal-title":"J Mol Med (Berl)"},{"key":"10671_CR29","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1136\/gutjnl-2014-308483","volume":"65","author":"E Villa","year":"2016","unstructured":"Villa E, Critelli R, Lei B et al (2016) Neoangiogenesis-related genes are hallmarks of fast-growing hepatocellular carcinomas and worst survival Results from a prospective study. Gut 65:861\u2013869","journal-title":"Gut"},{"key":"10671_CR30","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1002\/hep.30814","volume":"71","author":"SL Renne","year":"2020","unstructured":"Renne SL, Woo HY, Allegra S et al (2020) Vessels encapsulating tumor clusters (VETC) is a powerful predictor of aggressive hepatocellular carcinoma. Hepatology 71:183\u2013195","journal-title":"Hepatology"},{"key":"10671_CR31","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1148\/radiol.2021203614","volume":"300","author":"Z Feng","year":"2021","unstructured":"Feng Z, Li H, Zhao H et al (2021) Preoperative CT for characterization of aggressive macrotrabecular-massive subtype and vessels that encapsulate tumor clusters pattern in hepatocellular carcinoma. Radiology 300:219\u2013229","journal-title":"Radiology"},{"key":"10671_CR32","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1148\/radiol.14132361","volume":"272","author":"JY Choi","year":"2014","unstructured":"Choi JY, Lee JM, Sirlin CB (2014) CT and MR imaging diagnosis and staging of hepatocellular carcinoma: part I. Development, growth, and spread: key pathologic and imaging aspects. Radiology 272:635\u2013654","journal-title":"Radiology"},{"key":"10671_CR33","doi-asserted-by":"publisher","first-page":"948","DOI":"10.1007\/s00261-021-03392-2","volume":"47","author":"H Yang","year":"2022","unstructured":"Yang H, Han P, Huang M et al (2022) The role of gadoxetic acid-enhanced MRI features for predicting microvascular invasion in patients with hepatocellular carcinoma. Abdom Radiol (NY) 47:948\u2013956","journal-title":"Abdom Radiol (NY)"},{"key":"10671_CR34","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1016\/j.jhep.2017.04.024","volume":"67","author":"S Lee","year":"2017","unstructured":"Lee S, Kim SH, Lee JE, Sinn DH, Park CK (2017) Preoperative gadoxetic acid-enhanced MRI for predicting microvascular invasion in patients with single hepatocellular carcinoma. J Hepatol 67:526\u2013534","journal-title":"J Hepatol"},{"key":"10671_CR35","unstructured":"(2018) https:\/\/www.acr.org\/-\/media\/ACR\/Files\/RADS\/LI-RADS\/LI-RADS-2018-Core.pdf?la=en. The American College of Radiology LI-RADS v2018 Core"},{"key":"10671_CR36","doi-asserted-by":"publisher","first-page":"1611","DOI":"10.1148\/rg.2021210009","volume":"41","author":"KJ Fowler","year":"2021","unstructured":"Fowler KJ, Burgoyne A, Fraum TJ et al (2021) Pathologic, molecular, and prognostic radiologic features of hepatocellular carcinoma. Radiographics 41:1611\u20131631","journal-title":"Radiographics"},{"key":"10671_CR37","doi-asserted-by":"publisher","first-page":"e221429","DOI":"10.1148\/radiol.221429","volume":"307","author":"M Ronot","year":"2023","unstructured":"Ronot M, Chernyak V, Burgoyne A et al (2023) Imaging to predict prognosis in hepatocellular carcinoma: current and future perspectives. Radiology 307:e221429","journal-title":"Radiology"}],"container-title":["European Radiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00330-024-10671-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00330-024-10671-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00330-024-10671-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,13]],"date-time":"2024-09-13T17:11:19Z","timestamp":1726247479000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00330-024-10671-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3,20]]},"references-count":37,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2024,10]]}},"alternative-id":["10671"],"URL":"https:\/\/doi.org\/10.1007\/s00330-024-10671-1","relation":{},"ISSN":["1432-1084"],"issn-type":[{"value":"1432-1084","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,3,20]]},"assertion":[{"value":"6 November 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 February 2024","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 February 2024","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 March 2024","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The scientific guarantor of this publication is Victoria Chernyak, MD, MS.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Guarantor"}},{"value":"Richard K. Do is currently consultant to Bayer Healthcare and to GE Healthcare and advisory board member to Ascelia Pharma.Victoria Chernyak is currently consultant to Bayer Healthcare and to Giliad.Victoria Chernyak is also a member of the European Radiology Editorial Board. They have not taken part in the review or selection process of this article.Dong Ho Lee receives research grants from Canon medical systems.All other authors have no conflict of interest to declare.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"One of the authors (Tae-Hyung Kim) has significant statistical expertise.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Statistics and biometry"}},{"value":"Written informed consent was not required for this study because it was systematic review and meta-analysis.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"Institutional Review Board approval was not required because it was systematic review and meta-analysis.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"As this was a systematic review and meta-analysis, we utilized previously published articles to synthesize results.","order":7,"name":"Ethics","group":{"name":"EthicsHeading","label":"Study subjects or cohorts overlap"}},{"value":"\u2022 multicentre study","order":8,"name":"Ethics","group":{"name":"EthicsHeading","label":"Methodology"}}]}}